Introduccion La labor pretrmino (LPT) precede el 50% de partos pretrmino, pero aproximadamente el 30% se resuelve espontanemente y slo el 10% da a luz en los primeros 7 das (el 50% de las pacientes hospitalizadas por LPT tiene un parto a termino). La terapia tocoltica cesa las contracciones tempralmente, pero no remueve el estimulo causal; por lo que es util para horas a dias, pero no para semanas o meses. No partner Systemic infection Low socioeconomic status Bacteriuria Anxiety Periodontal disease Depression Placenta previa Life events (divorce, separation, death) Placental abruption Occupational issues Vaginal bleeding, especially in more than one trimester Abdominal surgery during pregnancy Previous preterm delivery Multiple gestation Substance abuse Polyhydramnios Smoking Uterine anomaly Maternal age (<18 or >40) Uterine leiomyoma African-American race Diethylstilbestrol-induced changes in uterus Poor nutrition and low body mass index History of second trimester abortion Inadequate prenatal care History of cervical surgery Anemia (hemoglobin <10 g/dL) Premature cervical dilatation or effacement (short cervical length) Excessive uterine contractility Sexually transmitted infections Low level of educational achievement Pyelonephritis, appendicitis, pneumonia Genotype Systemic infection Fetal anomaly Environmental factors (eg, heat, air pollution) Fetal growth restriction Labor pretrmino Clnica no especfica (puede presentarse varias horas antes) Clicos parecidos a menstrual Contracciones leves e irregulares Dolor lumbar Sensacin de presin en la vagina Secrecin vaginal de moco (claro, rosa o ligr sanguinolento)
Dx: Clnico. Eco tv es la mejor manera de medir cuello (<30cm riesgo) Contracciones: 4 every 20 minutes or 8 every 60 minutes. Incorporacin 80%; dilatacin >2cm. Triaje basado en longitud de cuelo (>30cm: bajo riesgo 20cm: alto riesgo) Fibronectina fetal como predictor. (ayuda a diferenciar de Braxton Higgs) Indicaciones Slo indicado en gestantes con una edad gestacional en la que el feto se beneficia de un retraso de 48h del parto. 1. Evaluacin inicial 2. Objetivos: 1) Demorar parto al menos 48h para alcanzar efecto mximo profilctico de corticoides. 2) Dar tiempo para el traslado de la madre. 3) Si se sospecha de causa transitoria (infecciosa o ciruga) 3. Contraindicaciones: Muerte fetal Anomala fetal letal Status fetal no reactivo Preeclampsia o eclampsia severa Hemorragia materna con inestabilidad hemodinmica Infeccin intraamnitica Contraindicacin materna a la droga tocoltica
Tratamiento Systematic review and network meta-analysis of 95 randomized trials of tocolytic therapy for preterm labor, all of the commonly used tocolytic agents (cyclooxygenase inhibitors, beta-adrenergic receptor agonist, calcium channel blockers, magnesium sulfate, oxytocin receptor antagonists) were statistically more effective than placebo/no therapy for delaying delivery for 48 hours (odds ratios compared toplacebo/no treatment ranged from 1.91 to 5.39) [18]. Cyclooxygenase inhibitors and calcium channel blockers had the highest probability of delaying delivery and improving neonatal and maternal outcomes. However, prolongation of pregnancy was not associated with a statistically significant reduction in overall rates of respiratory distress syndrome or neonatal death. This may be related to the rarity of neonatal death and inconsistency in definitions and reported outcomes among trials. Haas DM, Caldwell DM, Kirkpatrick P, et al. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012; 345:e6226.
Atosiban Inhibidor competitivo de receptores de oxitocina. FDA no lo aprob. Us en Europa. A recent Cochrane review (Papatsonis et al, 2005) did not demonstrate any superiority of atosiban over beta-agonists or placebo in terms of tocolytic efficacy or infant outcomes. Compared with beta-agonists, there were more atosiban- exposed infants with birth weights under 1500 gms (RR 1.96; 95% CI 1.15 to 3.35, 2 trials, 575 infants), and no overall clear benefit on in perinatal or neonatal outcomes Initial intravenous injection of 6.75mg in 0.9ml slowly injected over one minute A continuous infusion at a rate of 24 ml/hr up to 3 hours A continuous infusion at a rate of 8ml/hr up to 45 hours
Inhibidores Ciclooxigenasa (indometacina) Por su eficacia, seguridad y costo-efectividad, se considera de primera linea hasta las 32ss. (2-A) Prostaglandinas son esenciales para el labor de parto. Tanto la COX1 como la COX2 son producidas por la placenta, teniendo ms importantcia la COX2 durante el parto. Compared to the other drugs, COX inhibitors were associated with a trend toward reduction of birth within 48 hours of initiation of treatment (RR 0.59, 95% CI 0.34-1.02) The effect was more robust when COX inhibition was only compared with beta-adrenergic receptor agonists (RR 0.27, 95% CI 0.08-0.96). 50 to 100 mg loading dose (may be given per rectum), followed by 25 mg orally every four to six hours If indomethacin is continued for longer than 48 hours, sonographic evaluation for oligohydramnios and narrowing of the fetal ductus arteriosus is warranted at least weekly Informacin limitada sobre COX2 selectivos. Bloqueadores de canales de calcio Disminuye el ingreso y liberacin por el retculo sarcoplasmtico de Ca, lo que disminuye la interaccin entre cadenas de actina y miosina, disminuyendo contractibilidad. Compare with Beta-agonist, use of nifedipine was also associated with significant reductions in risk of respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage, neonatal jaundice, and admission to the neonatal intensive care unit, and had a better side effect profile. De primera linea entre las 32 y 34ss. (2-B) 30 mg loading dose and then 10 to 20 mg every four to six hours Agonistas beta adrenrgicos ( terbutaline) Se une al receptor beta-2 e incrementa adenil ciclasa intracelular, activando a la proteinkinasa y fosforilando proteinas intracelulares, lo que disminuye el Ca libre y finalmente, la interaccion entre actina y miosina, disminuyendo la contractibilidad. 0.25 mg can be administered every 20 to 30 minutes for up to four doses or until tocolysis is achieved Monitorizar FC materna (parar si >120xmin), K y glucosa. Sulfato de Magnesio Mecanismo de accin no claro. Compite con calcio en membrana celular. In 15 comparative trials, magnesium sulfate was neither more nor less effective than other tocolytics. Review from 4 meta-analisis evidence there was no evidence of a clinically important tocolytic effect of magnesium sulfate Efecto neuroprotector sobre neonato. (We limit magnesium sulfate for neuroprotection to pregnancies less than 32 weeks of gestation). Descontinuar tras 24h. Este efecto no debe condicionar eleccin de tocoltico. 6 g intravenous load over 20 minutes, followed by a continuous infusion of 2 g/hour. Puede ajustarse de acuerdo a toxicidad materna y efectividad en contracciones.
Donadores de oxido ntrico Incrementa el cGMP mediante la interaccin la guanilato ciclasa. Esto interacciona con la cadena de miosina produciendo relajacin del musculo liso. There is insufficient evidence to recommend NO donors for inhibition of preterm labor 10 mg glyceryl trinitrate patch applied to the skin of the abdomen. Aumentar otro parche si fuera necesario. 10ug/min en infusin intravenosa. Referencias UPTODATE American College of Obstetricians and Gynecologists, Committee on Practice BulletinsObstetrics. ACOG practice bulletin no. 127: Management of preterm labor. Obstet Gynecol 2012; 119:1308. King JF, Grant A, Keirse MJ, Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 1988; 95:211. Gazmararian JA, Petersen R, Jamieson DJ, et al. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol 2002; 100:94. Scott CL, Chavez GF, Atrash HK, et al. Hospitalizations for severe complications of pregnancy, 1987-1992. Obstet Gynecol 1997; 90:225. McPheeters ML, Miller WC, Hartmann KE, et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005; 192:1325. Fuchs IB, Henrich W, Osthues K, Dudenhausen JW. Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labor. Ultrasound Obstet Gynecol 2004; 24:554.